Vitro Diagnostics (VODG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2024 | 10-2023 | 10-2022 | 10-2021 | 10-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 571 | 102 | 742 | 4,377 | 297 |
| Receivables | 206 | 120 | 74 | 128 | 152 |
| Inventories | 115 | 171 | 280 | 118 | 35 |
| Other current assets | 0 | 2,656 | 1,483 | 0 | 0 |
| TOTAL | $976 | $3,179 | $2,936 | $4,636 | $484 |
| Non-Current Assets | |||||
| PPE Net | 140 | 320 | 352 | 115 | 146 |
| Intangibles | 3,619 | 4,359 | 4,995 | 6,041 | 0 |
| Other Non-Current Assets | 355 | 485 | 291 | 337 | 395 |
| TOTAL | $4,113 | $5,164 | $5,638 | $6,493 | $541 |
| Total Assets | $5,089 | $8,344 | $8,574 | $11,129 | $1,025 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12 | 62 | 63 | 111 | 45 |
| Accounts payable and accrued liabilities | 2,164 | 2,289 | 605 | 60 | 79 |
| Accrued Expenses | 82 | 54 | 1,172 | 172 | 368 |
| Other current liabilities | 155 | N/A | N/A | N/A | N/A |
| TOTAL | $10,063 | $4,850 | $2,540 | $1,423 | $553 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,989 | 1,989 | 1,989 | 1,989 | 1,989 |
| Deferred Revenues | 525 | 525 | 650 | 500 | N/A |
| Other Non-Current Liabilities | 2,033 | 2,578 | 1,130 | 4,187 | 1,010 |
| TOTAL | $4,027 | $4,585 | $3,199 | $6,251 | $3,098 |
| Total Liabilities | $14,090 | $9,435 | $5,738 | $7,675 | $3,651 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,461 | 4,431 | 115,160 | 96,310 | 46,130 |
| Common Shares | 5 | 4 | 4 | 97 | 46 |
| Retained earnings | -37,950 | -28,076 | -22,719 | -15,859 | -11,338 |
| Other shareholders' equity | -84 | -84 | -84 | -84 | -84 |
| TOTAL | $-9,001 | $-1,091 | $2,836 | $3,455 | $-2,626 |
| Total Liabilities And Equity | $5,089 | $8,344 | $8,574 | $11,129 | $1,025 |